ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Developing an accurate genetic model for rhabdomyosarcoma therapy | Children's Research Institute / Dawn Chandler, PhD | Young Investigator Grants | 2007 | District of Columbia |
| Targeted Hyperactivation of PI3K/AKT in B-cell malignancies | Dana-Farber Cancer Institute / Vishal Khairnar, PhD | Young Investigator Grants | 2019 | Massachusetts |
| Targeting HMGA1 in Childhood ALL | The Johns Hopkins University School of Medicine / Amy M. Belton, PhD | Young Investigator Grants | 2011 | Maryland |
| Targeting HMGA1 in Pediatric T-cell Acute Lymphoblastic Leukemia | The Johns Hopkins University School of Medicine / Joelle Hillion, PhD | Young Investigator Grants | 2008 | Maryland |
| Donor T-Cell DNA Methylation in GVHD and the Graft-vs-Tumor Effect after Allogeneic Hematopoietic Stem Cell Transplant | The Johns Hopkins University School of Medicine / Yiouli Panayiota Ktena, MD | Young Investigator Grants | 2020 | Maryland |
| Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics | Hospital for Sick Children / Vijay Ramaswamy, MD | Young Investigator Grants | 2014 | Ontario |
| MicroRNAs 100 and 125b in Ewing sarcoma | University of Colorado Denver / Paul Jedlicka | Young Investigator Grants | 2010 | Colorado |
| Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors | Jewish General Hospital / Bárbara Rivera, PhD | Young Investigator Grants | 2017 | Quebec |
| PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia | Massachusetts General Hospital / Jessica Blackburn, PhD | Young Investigator Grants | 2013 | Massachusetts |
| Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma. | Massachusetts General Hospital / David Langenau | Young Investigator Grants | 2009 | Massachusetts |